Europe Monoclonal Antibodies Market Share

Statistics for the 2023 & 2024 Europe Monoclonal Antibodies market share, created by Mordor Intelligence™ Industry Reports. Europe Monoclonal Antibodies share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Europe Monoclonal Antibodies Industry

The Europe monoclonal antibodies market is consolidated due to a few large companies dominating the majority of the market share. The prominent players are actively participating in the launch of mAbs for various applications. Some of the key players in the market include Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Novartis AG, Merck KGaA, and Pfizer Inc., among others.

Europe Monoclonal Antibodies Market Leaders

  1. Eli Lilly and Company

  2. F. Hoffmann-La Roche Ltd

  3. Novartis AG

  4. Merck KGaA

  5. Pfizer Inc.

*Disclaimer: Major Players sorted in no particular order

Europe Monoclonal Antibodies Market Concentration

Europe Monoclonal Antibodies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)